★ INSERT COIN◆NOW PLAYING: VENTURES◆HIGH SCORE: $100M ARR◆★ NEW STAGE UNLOCKED: ABOUT ME◆PRESS START◆★ DEMO DAY 04:00:00◆
★ INSERT COIN◆NOW PLAYING: VENTURES◆HIGH SCORE: $100M ARR◆★ NEW STAGE UNLOCKED: ABOUT ME◆PRESS START◆★ DEMO DAY 04:00:00◆
◀ BACK TO FEED
NEWS★ HEALTHTECHNOV 9, 2026

OpenEvidence adds ACP clinical guidance through a licensing deal

Medical AI needs dependable reference material as well as capable models.

OpenEvidence adds ACP clinical guidance through a licensing deal

Medical AI needs dependable reference material as well as capable models.

What happened

OpenEvidence and the American College of Physicians announced a licensing agreement covering ACP clinical guidance and content from Annals of Internal Medicine. Financial terms were not disclosed. The agreement is separate from OpenEvidence's earlier education-platform launch and rheumatology partnership.

Why it matters

Access to established clinical material can strengthen the evidence available inside a decision-support product. It also makes content partnerships an important part of the product's development.

The bigger picture

A licensing agreement is not clinical validation. Accuracy, appropriate interpretation and patient outcomes need their own evidence, with clinicians retaining responsibility for care decisions.